Optos reports 16% rise in 2008 revenue
Optos plc, a maker of medical imaging technology, posted a 16 percent rise in revenue for the year to end September, and said it was confident about its prospects.
Glaxo cuts further 200 UK jobs
GlaxoSmithKline is cutting a further 200 jobs at a factory in north-east England that makes its anti-nausea drug Zofran, a spokeswoman for the world's second biggest drugmaker said on Wednesday.
Newron secures CHF30m in equity funding agreement
R&D company Newron Pharmaceuticals SpA announced December 3, it has entered into an equity funding agreement with YA Global Investments to raise up to 30 million Swiss francs.
EU extends review of Teva bid for Barr Pharmaceutical
The European Commission today, December 12, extended its review of Israeli drugmaker Teva Pharmaceutical's bid to acquire U.S. biopharmaceutical and generic drugs marketer Barr Pharmaceuticals Inc.
Prospects of $45 bln loan for Roche receding
The prospects of Swiss drugmaker Roche raising a $45 billion (29.3 billion pound) syndicated loan to finance the buyout of the rest of U.S. biotech group Genentech are becoming increasingly remote.
Goldshield H1 profit up 44%, to increase interim dividend
Goldshield Group plc said on Friday, November 28, half-year revenues increased by 23 percent, after strong growth in its pharmaceutical and consumer health products units.